Two Sigma Advisers’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-68,340
| Closed | -$18.8M | – | 425 |
|
|
2025
Q4 | $18.8M | Sell |
68,340
-150,060
| -69% | -$42.1M | 0.04% | 373 |
|
|
2025
Q3 | $63M | Sell |
218,400
-87,900
| -29% | -$26M | 0.13% | 152 |
|
|
2025
Q2 | $101M | Sell |
306,300
-211,300
| -41% | -$68.1M | 0.21% | 105 |
|
|
2025
Q1 | $170M | Sell |
517,600
-298,600
| -37% | -$90M | 0.38% | 58 |
|
|
2024
Q4 | $225M | Buy |
816,200
+600,300
| +278% | +$191M | 0.52% | 45 |
|
|
2024
Q3 | $74.8M | Buy |
215,900
+196,200
| +996% | +$67.5M | 0.18% | 113 |
|
|
2024
Q2 | $6.51M | Sell |
19,700
-216,100
| -92% | -$74.5M | 0.01% | 673 |
|
|
2024
Q1 | $85.6M | Buy |
235,800
+223,500
| +1,817% | +$73.6M | 0.2% | 109 |
|
|
2023
Q4 | $3.68M | Buy |
12,300
+11,300
| +1,130% | +$3.3M | 0.01% | 956 |
|
|
2023
Q3 | $286K | Sell |
1,000
-12,000
| -92% | -$3.42M | ﹤0.01% | 1995 |
|
|
2023
Q2 | $3.65M | Sell |
13,000
-37,200
| -74% | -$9.69M | 0.01% | 900 |
|
|
2023
Q1 | $12.8M | Buy |
+50,200
| New | +$14.6M | 0.03% | 466 |
|
|
2022
Q4 | – | Sell |
-1,600
| Closed | -$444K | – | 2531 |
|
|
2022
Q3 | $444K | Sell |
1,600
-19,500
| -92% | -$5.49M | ﹤0.01% | 1887 |
|
|
2022
Q2 | $5.56M | Buy |
+21,100
| New | +$5.44M | 0.02% | 724 |
|
|
2020
Q4 | – | Sell |
-7,946
| Closed | -$1.35M | – | 2412 |
|
|
2020
Q3 | $1.35M | Sell |
7,946
-18,673
| -70% | -$3.29M | ﹤0.01% | 1367 |
|
|
2020
Q2 | $5M | Buy |
26,619
+12,119
| +84% | +$2.3M | 0.01% | 798 |
|
|
2020
Q1 | $2.57M | Buy |
+14,500
| New | +$2.81M | 0.01% | 980 |
|
|
2019
Q1 | – | Sell |
-457,994
| Closed | -$87M | – | 2312 |
|
|
2018
Q4 | $87M | Sell |
457,994
-573,930
| -56% | -$120M | 0.24% | 114 |
|
|
2018
Q3 | $215M | Buy |
1,031,924
+502,900
| +95% | +$93.2M | 0.52% | 39 |
|
|
2018
Q2 | $89.9M | Buy |
529,024
+70,700
| +15% | +$12.2M | 0.24% | 104 |
|
|
2018
Q1 | $76.9M | Sell |
458,324
-13,200
| -3% | -$2.57M | 0.21% | 132 |
|
|
2017
Q4 | $95.8M | Buy |
471,524
+45,520
| +11% | +$9.06M | 0.26% | 104 |
|
|
2017
Q3 | $79.6M | Sell |
426,004
-785,057
| -65% | -$140M | 0.23% | 125 |
|
|
2017
Q2 | $203M | Buy |
1,211,061
+420,237
| +53% | +$67.5M | 0.67% | 18 |
|
|
2017
Q1 | $116M | Buy |
790,824
+158,490
| +25% | +$23.4M | 0.38% | 53 |
|
|
2016
Q4 | $84.3M | Sell |
632,334
-116,557
| -16% | -$15.3M | 0.32% | 78 |
|
|
2016
Q3 | $97.6M | Buy |
748,891
+19,800
| +3% | +$2.59M | 0.42% | 54 |
|
|
2016
Q2 | $93.3M | Buy |
729,091
+208,300
| +40% | +$27.5M | 0.47% | 49 |
|
|
2016
Q1 | $71.5M | Buy |
520,791
+354,359
| +213% | +$48.7M | 0.4% | 63 |
|
|
2015
Q4 | $24.4M | Buy |
166,432
+144,698
| +666% | +$19.9M | 0.15% | 179 |
|
|
2015
Q3 | $2.94M | Buy |
+21,734
| New | +$3.16M | 0.02% | 622 |
|
|
2015
Q1 | – | Sell |
-117,885
| Closed | -$12.1M | – | 1961 |
|
|
2014
Q4 | $12.1M | Buy |
117,885
+112,200
| +1,974% | +$11.1M | 0.09% | 266 |
|
|
2014
Q3 | $516K | Sell |
5,685
-106,900
| -95% | -$9.99M | ﹤0.01% | 1517 |
|
|
2014
Q2 | $10.4M | Buy |
112,585
+102,800
| +1,051% | +$8.82M | 0.08% | 279 |
|
|
2014
Q1 | $819K | Buy |
9,785
+4,500
| +85% | +$371K | 0.01% | 1271 |
|
|
2013
Q4 | $462K | Buy |
+5,285
| New | +$432K | ﹤0.01% | 1646 |
|
Other funds holding CI
VCM
VPM
Two Sigma Advisers's CI Position: Q1 2026 in Review
Two Sigma Advisers sold out of Cigna (CI) in Q1 2026, closing a stake of 68,340 shares — an estimated $18.8M sold.
Two Sigma Advisers first reported a position in CI in Q4 2013 and held it in 36 quarters. The position peaked at $225M in Q4 2024. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.
- Two Sigma Advisers reported no remaining Cigna position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 68,340 Cigna shares in Q1 2026, an estimated $18.8M.
- Two Sigma Advisers first reported a position in Cigna in Q4 2013 and held it in 36 quarters.
- Two Sigma Advisers's Cigna position peaked at $225M in Q4 2024.
- 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.